The antifungal azole derivatives ketoconazole and posaconazole have shown some efficacy in targeting HK2 and inducing apoptosis in cancer cell models [107], and one phase 0 and two early phase 1 clinical trials are starting in glioma patients. This evidence concerns the gene HK2 and cancer.